Please assess the completion status of the following clinical trial:

Trial Title: A New Active Vitamin D, ED-71 for Osteoporosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Osteoporotic patients who meet any of the following condition:~  1. with at least one fragility fracture,~ 2. above 70 year-old with bone mineral density below 70% young adult mean,~ 3. with bone mineral density below 60% young adult mean~* Women three years or more after menopause or men~Exclusion Criteria:~* Current disorders such as primary hyperparathyroidism, Cushing's syndrome,gonadal insufficiency, poorly controlled diabetes mellitus or other causes of secondary osteoporosis~* A history or suspicion of active urolithiasis at any time~* Use of bisphosphonates in the past 12 months~* Use of medications known to affect bone in the past 2 months~* Abnormal serum calcium, urinary calcium, serum creatinine or liver function tests

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).